Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study

BACKGROUND: Checkpoint inhibitors in melanoma can lead to self-immune side-effects such as vitiligo-like depigmentation (VLD). Beyond the reported association with favorable prognosis, there are limited data regarding VLD patient features and their echo on the therapeutic outcomes. METHODS: To asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Guida, M., Strippoli, S., Maule, M., Quaglino, P., Ramondetta, A., Chiaron Sileni, V., Antonini Cappellini, G., Queirolo, P., Ridolfi, L., Del Vecchio, M., Cocorocchio, E., Di Giacomo, A.M., Festino, L., Merelli, B., Occelli, M., Brugnara, S., Minisini, A., Sava, S., Tommasi, S., De Summa, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970061/
https://www.ncbi.nlm.nih.gov/pubmed/33711672
http://dx.doi.org/10.1016/j.esmoop.2021.100064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970061/
https://www.ncbi.nlm.nih.gov/pubmed/33711672
http://dx.doi.org/10.1016/j.esmoop.2021.100064

Ejemplares similares